BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7929662)

  • 1. Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.
    Laruelle M; Wallace E; Seibyl JP; Baldwin RM; Zea-Ponce Y; Zoghbi SS; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):982-94. PubMed ID: 7929662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.
    Bonab AA; Fischman AJ; Alpert NM
    J Nucl Med; 2000 Jun; 41(6):1086-92. PubMed ID: 10855640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB
    J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primates.
    Scanley BE; Gandelman MS; Laruelle M; Al-Tikriti MS; Baldwin RM; Zoghbi SS; Hoffer PB; Wang S; Neumeyer JL; Innis RB
    Nucl Med Biol; 2000 Jan; 27(1):13-21. PubMed ID: 10755641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT; Akerman K; Bergström KA; Karhu J; Hiltunen J; Haukka J; Heikkinen J; Tiihonen J; Wang S; Neumeyer JL
    Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM; Zea-Ponce Y; Zoghbi SS; Laurelle M; al-Tikriti MS; Sybirska EH; Malison RT; Neumeyer JL; Milius RA; Wang S
    Nucl Med Biol; 1993 Jul; 20(5):597-606. PubMed ID: 8358345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT; Bergström KA; Ahonen A; Hiltunen J; Haukka J; Länsimies E; Wang S; Neumeyer JL
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M; Takatoku K; Matoba Y; Nishiura M; Kobayashi K; Inoue O; Nishimura T
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.